tiprankstipranks
Elicio Therapeutics announces completion of Phase 2 AMPLIFY-7P study enrollment
PremiumThe FlyElicio Therapeutics announces completion of Phase 2 AMPLIFY-7P study enrollment
3M ago
Elicio Therapeutics reports Q3 EPS ($1.39), consensus (73c)
Premium
The Fly
Elicio Therapeutics reports Q3 EPS ($1.39), consensus (73c)
3M ago
Elicio Therapeutics files to sell 3.44M shares of common stock for holders
Premium
The Fly
Elicio Therapeutics files to sell 3.44M shares of common stock for holders
3M ago
Elicio Therapeutics reports inducement grants
PremiumThe FlyElicio Therapeutics reports inducement grants
5M ago
KalVista names Brian Piekos as CFO
Premium
The Fly
KalVista names Brian Piekos as CFO
6M ago
Elicio Therapeutics CFO Brian Piekos Resigns Amicably
Premium
Company Announcements
Elicio Therapeutics CFO Brian Piekos Resigns Amicably
6M ago
Elicio: Preliminary analysis data of Phase 2 dose patients yet to reach endpoint
PremiumThe FlyElicio: Preliminary analysis data of Phase 2 dose patients yet to reach endpoint
8M ago
Elicio Therapeutics announces offering of common stock, no amount given
Premium
The Fly
Elicio Therapeutics announces offering of common stock, no amount given
8M ago
Elicio Therapeutics reports inducement grants
Premium
The Fly
Elicio Therapeutics reports inducement grants
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100